Abstract Background: Colorectal Cancer is the 5th common malig-nant tumor among Egyptians representing 5% of the total cancers according to National Cancer Registry 2013. Aim of Study: To evaluate association of serum level of Cyclin D1 and variants in MicroRNA196a-2 (miR196A2) rs11614913 and Deleted in colorectal cancer (DCC) rs714 genes with the risk of colorectal cancer and its progression. Patients and Methods: A case-control study was done on 100 colorectal cancer (CRC) patients and 60 healthy controls were enrolled and were genotyped for miR196A2 rs11614913 gene variation using the real time-Taq Man assay and DCC rs714 gene variation using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Serum levels of Cyclin D1 were measured by Enzyme linked immunosorbant assay (ELSA). Results: Pathogenic variant G of DCC was associated with an increased risk of colorectal cancer compared to A variant (p<0.001). Also, G variant (GG and GA genotypes) was associated with increased risk of distant metastasis in patients of CRC compared to DCC A variant (p=0.014). There was a significant association between increased serum level of Cyclin D 1 and the risk of colorectal cancer (p=0.001) with cut-off value >3.4ng/mL. Pathogenic variant C of miR196A2 was not significantly associated with increased risk of colorectal cancer (p=0.766) but showed a significant increase in tumor progression (p=0.013). Conclusion: Pathogenic variant G of DCC and increased serum level of Cyclin D1 are predictive factors of sporadic colorectal cancer among Egyptian patients. C variant of miR196A2 can be used as prognostic rather than diagnostic markers of CRC.
IMAN A. MANDOUR, M.D.*, N. M. S. M., EHSAN EL-GHONEIMY, M.D.**, R. E. M., RASHA M. ABDEL SAMIE, M.D.***, M. I. F. M., & T. ELSHEWY, M.D.*, Y. (2022). Association of Serum Cyclin D1 and Variations of MIR 196A2 and Deleted in Colorectal Cancer (DCC) Genes with Colorectal Cancer. The Medical Journal of Cairo University, 90(12), 2767-2775. doi: 10.21608/mjcu.2022.296227
MLA
NORA M. SELIM, M.D.*; IMAN A. MANDOUR, M.D.*; RIHAM El-SAYED, M.D.*; EHSAN EL-GHONEIMY, M.D.**; MAYSA I. FARGHALY, M.D.*; RASHA M. ABDEL SAMIE, M.D.***; YASMIN T. ELSHEWY, M.D.*. "Association of Serum Cyclin D1 and Variations of MIR 196A2 and Deleted in Colorectal Cancer (DCC) Genes with Colorectal Cancer", The Medical Journal of Cairo University, 90, 12, 2022, 2767-2775. doi: 10.21608/mjcu.2022.296227
HARVARD
IMAN A. MANDOUR, M.D.*, N. M. S. M., EHSAN EL-GHONEIMY, M.D.**, R. E. M., RASHA M. ABDEL SAMIE, M.D.***, M. I. F. M., T. ELSHEWY, M.D.*, Y. (2022). 'Association of Serum Cyclin D1 and Variations of MIR 196A2 and Deleted in Colorectal Cancer (DCC) Genes with Colorectal Cancer', The Medical Journal of Cairo University, 90(12), pp. 2767-2775. doi: 10.21608/mjcu.2022.296227
VANCOUVER
IMAN A. MANDOUR, M.D.*, N. M. S. M., EHSAN EL-GHONEIMY, M.D.**, R. E. M., RASHA M. ABDEL SAMIE, M.D.***, M. I. F. M., T. ELSHEWY, M.D.*, Y. Association of Serum Cyclin D1 and Variations of MIR 196A2 and Deleted in Colorectal Cancer (DCC) Genes with Colorectal Cancer. The Medical Journal of Cairo University, 2022; 90(12): 2767-2775. doi: 10.21608/mjcu.2022.296227